Stryker (SYK) Research & Development (2009 - 2026)
Stryker (SYK) posted quarterly Research & Development of $434.0 million for Q2 2026, up 6.63% year-over-year from $407.0 million in Q2 2025, and up 5.08% on a QoQ basis from $413.0 million in Q1 2026.
Stryker (SYK) Research & Development (2009 - 2026) Analysis & Trends
Stryker has reported Research & Development for 18 years, with the latest figure at $434.0 million in Q2 2026.
- Research & Development for Q2 2026 came in at $434.0 million, up 6.63% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.7 billion (up 7.18% YoY), and the FY2025 annual result was $1.6 billion, up 10.71% from the prior year.
- Research & Development improved to $434.0 million in Q2 2026, from $413.0 million in the prior quarter.
- Over five years, Research & Development peaked at $434.0 million in Q2 2026 and troughed at $326.0 million in Q4 2022.
- A 5-year average of $376.6 million and a median of $366.0 million in 2022 frame the typical range for Research & Development.
- The widest annual swing landed in 2022, when Research & Development soared 43.4%; it then declined 17.92% in 2023.
- A 5-year view of Research & Development shows it stood at $326.0 million in 2022, then gained by 7.36% to $350.0 million in 2023, then rose by 2.29% to $358.0 million in 2024, then advanced by 12.01% to $401.0 million in 2025, then rose by 8.23% to $434.0 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $434.0 million in Q2 2026, $413.0 million in Q1 2026, and $401.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.90 Bn | 194.30 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 130.01 Bn | 126.54 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.53 Bn | 111.31 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.77 Bn | 74.24 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.43 Bn | 19.02 Bn | 1.54 Bn | 104.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 434.00 Mn |
| Mar 31, 2026 | 413.00 Mn |
| Dec 31, 2025 | 401.00 Mn |
| Sep 30, 2025 | 410.00 Mn |
| Jun 30, 2025 | 407.00 Mn |
| Mar 31, 2025 | 405.00 Mn |
| Dec 31, 2024 | 358.00 Mn |
| Sep 30, 2024 | 377.00 Mn |
| Jun 30, 2024 | 363.00 Mn |
| Mar 31, 2024 | 368.00 Mn |
| Dec 31, 2023 | 350.00 Mn |
| Sep 30, 2023 | 353.00 Mn |
| Jun 30, 2023 | 346.00 Mn |
| Mar 31, 2023 | 339.00 Mn |
| Dec 31, 2022 | 326.00 Mn |
| Sep 30, 2022 | 364.00 Mn |
| Jun 30, 2022 | 351.00 Mn |
| Mar 31, 2022 | 413.00 Mn |
| Dec 31, 2021 | 331.00 Mn |
| Sep 30, 2021 | 306.00 Mn |